These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 19745749)

  • 1. Disentangling the Babylonian speech confusion in genetic counseling: an analysis of the reliability and validity of the nomenclature for BRCA1/2 DNA-test results other than pathogenic.
    Vos J; van Asperen CJ; Wijnen JT; Stiggelbout AM; Tibben A
    Genet Med; 2009 Oct; 11(10):742-9. PubMed ID: 19745749
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Opening the psychological black box in genetic counseling. The psychological impact of DNA testing is predicted by the counselees' perception, the medical impact by the pathogenic or uninformative BRCA1/2-result.
    Vos J; Gómez-García E; Oosterwijk JC; Menko FH; Stoel RD; van Asperen CJ; Jansen AM; Stiggelbout AM; Tibben A
    Psychooncology; 2012 Jan; 21(1):29-42. PubMed ID: 21072753
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Key messages for communicating information about BRCA1 and BRCA2 to women with breast or ovarian cancer: Consensus across health professionals and service users.
    Jacobs C; Pichert G; Harris J; Tucker K; Michie S
    Psychooncology; 2017 Nov; 26(11):1818-1824. PubMed ID: 28101941
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Patients' resistance to risk information in genetic counseling for BRCA1/2.
    Gurmankin AD; Domchek S; Stopfer J; Fels C; Armstrong K
    Arch Intern Med; 2005 Mar; 165(5):523-9. PubMed ID: 15767527
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Cognitive, emotional and behavioral impact of an uncertain outcome after study of BRCA1/2: review of the literature].
    Leblond D; Brédart A; Dolbeault S; De Pauw A; Stoppa Lyonnet D; Flahault C; Sultan S
    Bull Cancer; 2011 Feb; 98(2):184-98. PubMed ID: 21382771
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cancer genetics knowledge and beliefs and receipt of results in Ashkenazi Jewish individuals receiving counseling for BRCA1/2 mutations.
    Kelly K; Leventhal H; Marvin M; Toppmeyer D; Baran J; Schwalb M
    Cancer Control; 2004; 11(4):236-44. PubMed ID: 15284715
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Psychosocial issues following a positive result of genetic testing for BRCA1 and BRCA2 mutations: findings from a focus group and a needs-assessment survey.
    Di Prospero LS; Seminsky M; Honeyford J; Doan B; Franssen E; Meschino W; Chart P; Warner E
    CMAJ; 2001 Apr; 164(7):1005-9. PubMed ID: 11314429
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical interpretation and recommendations for patients with a variant of uncertain significance in BRCA1 or BRCA2: a survey of genetic counseling practice.
    Petrucelli N; Lazebnik N; Huelsman KM; Lazebnik RS
    Genet Test; 2002; 6(2):107-13. PubMed ID: 12215249
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Communicating genetic test results to the family: a six-step, skills-building strategy.
    Daly MB; Barsevick A; Miller SM; Buckman R; Costalas J; Montgomery S; Bingler R
    Fam Community Health; 2001 Oct; 24(3):13-26. PubMed ID: 11563941
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect on perceived control and psychological distress of genetic knowledge in women with breast cancer receiving a BRCA1/2 test result.
    Brédart A; Kop JL; De Pauw A; Caron O; Fajac A; Noguès C; Stoppa-Lyonnet D; Dolbeault S
    Breast; 2017 Feb; 31():121-127. PubMed ID: 27837705
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Perceiving cancer-risks and heredity-likelihood in genetic-counseling: how counselees recall and interpret BRCA 1/2-test results.
    Vos J; Oosterwijk JC; Gómez-García E; Menko FH; Jansen AM; Stoel RD; van Asperen CJ; Tibben A; Stiggelbout AM
    Clin Genet; 2011 Mar; 79(3):207-18. PubMed ID: 21114486
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Female family members lack understanding of indeterminate negative BRCA1/2 test results shared by probands.
    Himes DO; Gibbons DK; Birmingham WC; Beckstrand RL; Gammon A; Kinney AY; Clayton MF
    J Genet Couns; 2019 Oct; 28(5):950-961. PubMed ID: 31199558
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of the pathogenic variants of BRCA1 and BRCA2 using next-generation sequencing in women with familial breast cancer: a case-control study.
    Zayas-Villanueva OA; Campos-Acevedo LD; Lugo-Trampe JJ; Hernández-Barajas D; González-Guerrero JF; Noriega-Iriondo MF; Ramírez-Sánchez IA; Martínez-de-Villarreal LE
    BMC Cancer; 2019 Jul; 19(1):722. PubMed ID: 31331294
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Utilization of BRCA1/BRCA2 mutation testing in newly diagnosed breast cancer patients.
    Schwartz MD; Lerman C; Brogan B; Peshkin BN; Isaacs C; DeMarco T; Halbert CH; Pennanen M; Finch C
    Cancer Epidemiol Biomarkers Prev; 2005 Apr; 14(4):1003-7. PubMed ID: 15824179
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic counselor opinions of, and experiences with telephone communication of BRCA1/2 test results.
    Bradbury AR; Patrick-Miller L; Fetzer D; Egleston B; Cummings SA; Forman A; Bealin L; Peterson C; Corbman M; O'Connell J; Daly MB
    Clin Genet; 2011 Feb; 79(2):125-31. PubMed ID: 21039431
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A population-based study of Ashkenazi Jewish women's attitudes toward genetic discrimination and BRCA1/2 testing.
    Lehmann LS; Weeks JC; Klar N; Garber JE
    Genet Med; 2002; 4(5):346-52. PubMed ID: 12394347
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recruitment, genetic counseling, and BRCA testing for underserved women at a public hospital.
    Lee R; Beattie M; Crawford B; Mak J; Stewart N; Komaromy M; Esserman L; Shaw L; McLennan J; Strachowski L; Luce J; Ziegler J
    Genet Test; 2005; 9(4):306-12. PubMed ID: 16379544
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Information needs of mothers regarding communicating BRCA1/2 cancer genetic test results to their children.
    Tercyak KP; Peshkin BN; Demarco TA; Patenaude AF; Schneider KA; Garber JE; Valdimarsdottir HB; Schwartz MD
    Genet Test; 2007; 11(3):249-55. PubMed ID: 17949286
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk Assessment, Genetic Counseling, and Genetic Testing for BRCA-Related Cancer in Women: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force.
    Nelson HD; Pappas M; Cantor A; Haney E; Holmes R
    JAMA; 2019 Aug; 322(7):666-685. PubMed ID: 31429902
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Communication Between Breast Cancer Patients Who Received Inconclusive Genetic Test Results and Their Daughters and Sisters Years After Testing.
    Baars JE; Ausems MG; van Riel E; Kars MC; Bleiker EM
    J Genet Couns; 2016 Jun; 25(3):461-71. PubMed ID: 26446011
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.